We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostic Accuracy of Protein/Creatinine Ratio Influenced by Urine Concentration

By LabMedica International staff writers
Posted on 29 Sep 2015
Print article
The Clinitek Atlas Automated Urine Chemistry Analyzer
The Clinitek Atlas Automated Urine Chemistry Analyzer (Photo courtesy of Siemens Healthineers - Laboratory Diagnostics)
The diagnosis and management of proteinuric renal diseases and the staging of chronic kidney disease (CKD) require accurate identification and quantitation of proteinuria.

The usage of urine protein/creatinine ratio to estimate daily urine protein excretion is prevalent, but relatively little attention has been paid to the influence of urine concentration and its impact on test accuracy.

Scientists at the Taipei Veterans General Hospital (Taiwan) and their colleagues collected 540 urine samples with complete data of 24 hour urine protein concentration, creatinine concentration, total volume, and most importantly, a concomitant urinalysis of the same urine sample. After the total volume of the 24 hour urine sample had been measured and the storage container had been gently shaken for 10 seconds to mix the urine, two 10 mL specimens were sent for urinalysis and urine protein creatinine concentration measurement, respectively.

The urine protein and creatinine concentration of 24 hour and spot urine were both determined by the Hitachi 7180 Autoanalyzer (Hitachi; Tokyo, Japan). The specific gravity of the urinalysis was analyzed by using the Clinitek Atlas Automated Urine Chemistry Analyzer (Siemens Healthcare Diagnostics; Erlangen, Germany). In order to a compare distribution patterns of urine creatinine concentration between 24 hour and spot urine samples, a concurrent database of single voided urine samples collected during June 2010 to May 2014 were examined. Spot urine samples were collected at any time point of the day. There were 31,551 urine protein/creatinine ratio (UPCR) spot samples with a concomitant urinalysis examination.

The investigators found that found that for dilute urine samples with specific gravity equal to or less than 1.005, a sample with urine creatinine equal to or less than 38.8 mg/dL was more likely to overestimate actual daily urine protein excretion by using UPCR. For urine samples with specific gravity equal to or greater than 1.015, equal to or greater than 1.020, and equal to or greater than 1.025, those with urine creatinine concentration equal to or greater than 63.6 mg/dL, equal to or greater than 62.1 mg/dL, equal to or greater than 61.5 mg/dL, respectively, were more likely to lead to an underestimation.

The authors concluded that the UPCR in samples with low or high specific gravity is more likely to overestimate or underestimate actual daily urine protein amount, respectively, especially in a dilute urine sample with its creatinine below 38.8 mg/dL or a concentrated sample with its creatinine above 61.5 mg/dL. In particular, UPCR results should be interpreted with caution in cases that involve dilute urine samples because its overestimation may lead to an erroneous diagnosis of proteinuric renal disease or an incorrect staging of chronic kidney disease. The study was published on September 9, 2015, in the journal PLOS ONE.

Related Links:

Taipei Veterans General Hospital
Hitachi
Siemens Healthcare Diagnostics 


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Centrifuge
Hematocrit Centrifuge 7511M4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.